Lilly Ventures Fund I LLC 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 4:59 pm Sale | 2020-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Lilly Ventures Fund I LLC | 102,742 5.400% | -3,227 (-3.04%) | Filing |
| 2020-02-13 4:17 pm Purchase | 2019-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Lilly Ventures Fund I LLC | 105,968 9.100% | 656 (+0.62%) | Filing |